The WHO Tobacco Convention: A New Dawn in the Implementation of International Health Instrument?; Comment on “The Legal Strength of International Health Instruments - What It Brings to Global Health Governance?”

Document Type: Commentary

Author

Dullah Omar Institute, University of Western Cape, Cape Town, South Africa

Abstract

The Tobacco Convention was adopted by the World Health Organization (WHO) in 2003. Nikogosian and Kickbusch examine the five potential impacts of the Tobacco Convention and its Protocol on public health. These include the adoption of the Convention would seem to unlock the treaty-making powers of WHO; the impact of the Convention in the global health architecture has been phenomenal globally; the Convention has facilitated the adoption of further instruments to strengthen its implementation at the national level; the Convention has led to the adoption of appropriate legal framework to combat the use of tobacco at the national level and that the impact of the Convention would seem to go beyond public health but has also led to the adoption of the Protocol to Eliminate Illicit Trade in Tobacco. However, the article by Nikogosian and Kickbusch would seem to overlook some of the challenges that may militate against the effective implementation of international law, including the Tobacco Convention, at the national level.

Keywords

Main Subjects


  1. World Health Organisation (WHO). WHO Framework Convention on Tobacco Control. http://www.who.int/fctc/text_download/en.  Accessed April 12, 2017. Published 2003.
  2. United Nations Treaty Collections. WHO Framework Convention on Tobacco Control. https://treaties.un.org/pages/ViewDetails.aspx?src=TREATY&mtdsg_no=IX-4&chapter=9&clang=_en.  Accessed April 16, 2017.
  3. World Health Organisation (WHO). MPOWER: a policy package to reverse the tobacco epidemic. http://www.who.int/tobacco/mpower/mpower_english.pdf.   Accessed February 2, 2017.
  4. Nikogosian H, Kickbusch  H. The legal strength of international health instruments: what it brings to global health governance. Int J Health Policy Manag. 2016;5(12):683-685. doi:10.15171/ijhpm.2016.122
  5. Gravely S, Giovino GA, Craig L, et al. Implementation of key demand-reduction measures of the WHO Framework Convention on Tobacco Control and change in smoking prevalence in 126 countries: an association study. Lancet Public Health. 2017;2:e166-e174.
  6. Conference of the Parties (COP) to the WHO Framework Convention on Tobacco Control Impact Assessment of the WHO FCTC: Report by the Expert Group; November 7-12, 2016; Delhi, India.
  7. Mackey TK, Liang BA, Pierce JP, Huber L, Bostic C. Call to action: promoting domestic and global tobacco control by ratifying the framework convention on tobacco control in the United States. PLoS Med. 2004;11(5):e1001639. doi:10.1371/journal.pmed.1001639
  8. Minister of Health v Treatment Action Campaign and Others. 2002 10 BCLR 1033 (CC). https://www.escr-net.org/caselaw/2006/minister-health-v-treatment-action-campaign-tac-2002-5-sa-721-cc
  9. Chapman A. Human Rights Obligations of Non-state Actors. Oxford: Oxford University Press; 2006.
  10. Decisions of the First Session of the Conference of the Parties to the WHO Framework Convention on Tobacco Control. Geneva, Switzerland, February 6–17, 2006. Document A/FCTC/COP/1/DIV/8; March 23, 2006, p28. Decision FCTC/COP1(14)—Reporting and exchange of information. http://www.who.int/gb/fctc/PDF/cop1/FCTC_COP1_DIV8-en.pdf.
  11. The UN Human Rights Council. The Guiding Principles on Business and Human Rights for implementing the UN “Protect, Respect and Remedy” Framework. http://www.ohchr.org/Documents/Issues/Business/A-HRC-17-31_AEV.pdf.   Accessed April 17, 2017. Published June 16, 2011.
  12. Report on accountability and human rights guidelines for pharmaceutical companies in relation to access to medicines (A/ 63/263). Submitted to the General Assembly on August 11, 2008. http://www.who.int/medicines/areas/human_rights/A63_263.pdf.   Accessed April 7, 2017.